Renascience Inc.

4889

JP3981100005

Pharmaceuticals

Delayed Japan Exchange Other stock markets 08:03:03 2024-04-25 pm EDT			5-day change	1st Jan Change
342 ^JPY	-0.87%		+2.40%	-21.20%

2022	Certain Common Stock of Renascience Inc. are subject to a Lock-Up Agreement Ending on 22-MAR-2022.	CI
2021	Certain Common Stock of Renascience Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2021.	CI

Renascience Inc. has filed an IPO.

August 18, 2021 at 12:00 am EDT

Renascience Inc. has filed an IPO. Security Name: Common Stock Security Type: Common Stock Securities Offered: 2,951,400 Transaction Features: Sponsor Backed Offering

Latest news about Renascience Inc.

Certain Common Stock of Renascience Inc. are subject to a Lock-Up Agreement Ending on 22-MAR-2022.	22-03-21	CI
Certain Common Stock of Renascience Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2021.	21-12-22	CI
Renascience Inc. has completed an IPO in the amount of ?1.977438 billion.	21-09-24	CI
Renascience Inc. has filed an IPO.	21-08-18	CI

Renascience Inc is mainly engaged in the development and sale of pharmaceuticals and medical devices. The company is engaged in the research and development of various modalities (pharmaceuticals, medical devices, artificial intelligence (AI) solutions) to solve problems in the medical field, in collaboration with physicians. The Company is engaged in the development of drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The Company is also engaged in the solve of other medical issues such as diseases of women and children, and COVID-19 infection.

Sector

Pharmaceuticals

Calendar

2024-05-08 - Q4 2023 Earnings Release

More about the company

	1st Jan change	Capi.
RENASCIENCE INC.	-21.20%	28.28M
NOVO NORDISK A/S	+24.17%	562B
JOHNSON & JOHNSON	-6.33%	358B
MERCK & CO., INC.	+19.90%	322B
ABBVIE INC.	+7.95%	297B
ASTRAZENECA PLC	+13.45%	219B
NOVARTIS AG	+6.04%	199B
ROCHE HOLDING AG	-10.51%	196B
PFIZER, INC.	-12.26%	149B
AMGEN INC.	-6.47%	146B

Other Pharmaceuticals

Renascience Inc.

Equities

4889

JP3981100005

Pharmaceuticals

Renascience Inc. has filed an IPO.

Latest news about Renascience Inc.

Chart Renascience Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals